Biochemical entrepreneur with more than 25 years of experience in the biotech industry. Andreas has founded and co-founded several international biotech companies and has led organizations actively in the development and manufacturing of therapeutic antibodies and biosimilars in Europe and the US. His track record includes the creation and growth of companies valued at more than USD 700 million and transactions with major pharmaceutical companies including Roche, Pfizer, J&J, and Hospira.

Biologist by training with 15+ years of experience in the development of antibody therapeutics across oncology, immunology and neurological diseases. Roman has held senior academic and industry leadership roles, including Group Leader at the University of Stuttgart and Assistant Professor at Drexel University. Most recently, he led R&D activities in Regenerative Therapies at resano, a BioNTech company. He has authored 35+ publications with 3,000+ citations and contributed to 15+ patent applications.

Chemical engineer with a strong background in CMC and regulatory affairs. She has held leadership roles in process development and GMP manufacturing at Celonic GmbH and Celonic AG, and later served as Vice President Project Management at Alvotech, where she led cross-functional teams in the development of biosimilar products.

Experienced business development and project management professional with broad expertise in the development of biological entities and biosimilars. She gained extensive knowledge in protein characterization at SGS M-SCAN and supports the development of early-stage and preclinical programs as a PMI-certified project manager.